{"id":"W2596358769","doi":"10.1016/s0140-6736(17)30751-1","title":"Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Janssen Research and Development","keywords":"Rivaroxaban; Medicine; P2Y12; Aspirin; Clopidogrel; Internal medicine; Acute coronary syndrome; Double blind; Randomized controlled trial; Cardiology; Myocardial infarction; Atrial fibrillation; Warfarin; Alternative medicine; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003105118,0.003588092,0.007048604,0.0006146712,0.0007067729,0.001967883,0.001806309,0.003661123,0.008254288],"category_scores_gemma":[0.003329005,0.00147188,0.004069208,0.0007512233,0.00242941,0.002191716,0.0008149201,0.005589215,0.001807988],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00104959,"about_ca_system_score_gemma":0.001021354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001418372,"about_ca_topic_score_gemma":0.002624289,"domain_scores_codex":[0.9984691,0.0008099411,0.0001213854,0.0003085569,0.00009327056,0.0001976684],"domain_scores_gemma":[0.9986458,0.000466665,0.0002892227,0.0001698485,0.00007990102,0.0003485802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9931192,0.001027087,0.0001365286,0.0005931279,0.001125603,0.00002037867,0.00003329751,0.00009526753,0.0008044468,0.00006552001,0.0003479023,0.002631549],"study_design_scores_gemma":[0.9877609,0.01051024,0.000500125,0.00002372351,0.0006649297,0.00001675122,0.00001318551,0.0001360301,0.00008842719,0.00009066208,0.0001835181,0.00001140944],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9675393,0.01778163,0.001680668,0.002172716,0.002628547,0.003241674,0.001588732,0.0003551851,0.003011544],"genre_scores_gemma":[0.9734896,0.008552851,0.003036601,0.002367999,0.001988119,0.00339835,0.001821683,0.00007498748,0.00526975],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008254288,"threshold_uncertainty_score":0.02761334,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06708174095132563,"score_gpt":0.3419054428848061,"score_spread":0.2748237019334804,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}